Clinical trial
Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of…
NCT00263328 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00263328 |
|---|---|
| Title | Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient |
| Official title | A Multicenter, Phase 2, Open-label, Controlled, Extension Study For Stage 1 Subjects Of Study A3921009 To Evaluate The Long-term Safety And Efficacy Of Cp-690,550 Versus Tacrolimus, When Co-administered With Mycophenolate Mofetil In Renal Allograft Recipients |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | Tacrolimus, CP-690, 550 |
| Enrollment | 46 |
| Start date | Dec 1, 2005 |
| Primary completion | Jan 1, 2014 |
| Completion | Jun 1, 2014 |
| First posted | Dec 8, 2005 |
| Last update posted | Jul 13, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: